Young Richard A 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Young Richard A
Director
Transactions
- Exercise/Conversion
Common Stock
2023-09-16+2,666→ 38,837 total - Exercise/Conversion
Restricted Stock Units
2023-09-16−2,666→ 5,334 total→ Common Stock (2,666 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F3]Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023.